Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 10411 record(s)

Req # A-2023-001259

Adverse Drug Reactions (ADRs). Report numbers: E2B_04370904, E2B_06667368, E2B_06549930, E2B_06689043.

Organization: Health Canada

731 page(s)
June 2024

Req # A-2023-001262

Adverse Drug Reaction (ADR). Report number: E2B_0675480.

Organization: Health Canada

7 page(s)
June 2024

Req # A-2023-001305

Adverse Drug Reactions (ADRs) for Patiromer. Report numbers: E2B_06736931, E2B_06760211, E2B_06764503. ADR for Sucroferric oxyhydroxide. Report number: E2B_06724987. ADRs for Tavneos. Report numbers: E2B_06718319, E2B_06749489, E2B_06750903,…

Organization: Health Canada

84 page(s)
June 2024

Req # A-2023-001341

Adverse Drug Reactions (ADRs). Report numbers: 001068464, E2B_06179026.

Organization: Health Canada

35 page(s)
June 2024

Req # A-2023-001474

Adverse Drug Reaction (ADR). Report number: E2B_06331844.

Organization: Health Canada

18 page(s)
June 2024

Req # A-2023-001502

Adverse Drug Reaction (ADR) for Pazopanib. Report number: E2B_06819041.

Organization: Health Canada

8 page(s)
June 2024

Req # A-2023-001510

Adverse Drug Reaction (ADR) for DICLECTIN (doxylamine/pyridoxine). Report number: 001070859.

Organization: Health Canada

7 page(s)
June 2024

Req # A-2023-001511

Adverse Drug Reaction (ADR) for DICLECTIN (doxylamine/pyridoxine). Report number: 001070516.

Organization: Health Canada

5 page(s)
June 2024

Req # A-2023-001542

Adverse Drug Reactions (ADRs). Report numbers: E2B_06388027, 001051137, E2B_06450364, E2B_01526380, E2B_06515752.

Organization: Health Canada

298 page(s)
June 2024

Req # A-2023-001545

Adverse Drug Reactions (ADRs). Report numbers: E2B_06110117, E2B_06001457.

Organization: Health Canada

41 page(s)
June 2024
Date modified: